PE20150616A1 - Composicion que comprende factores de crecimiento obtenidos a partir del plasma sanguineo - Google Patents
Composicion que comprende factores de crecimiento obtenidos a partir del plasma sanguineoInfo
- Publication number
- PE20150616A1 PE20150616A1 PE2015000116A PE2015000116A PE20150616A1 PE 20150616 A1 PE20150616 A1 PE 20150616A1 PE 2015000116 A PE2015000116 A PE 2015000116A PE 2015000116 A PE2015000116 A PE 2015000116A PE 20150616 A1 PE20150616 A1 PE 20150616A1
- Authority
- PE
- Peru
- Prior art keywords
- growth factors
- composition
- blood plasma
- composition including
- including growth
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000003102 growth factor Substances 0.000 title abstract 4
- 210000002381 plasma Anatomy 0.000 title 1
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201200810A ES2442242B1 (es) | 2012-08-09 | 2012-08-09 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20150616A1 true PE20150616A1 (es) | 2015-05-25 |
Family
ID=49111229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015000116A PE20150616A1 (es) | 2012-08-09 | 2013-07-19 | Composicion que comprende factores de crecimiento obtenidos a partir del plasma sanguineo |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140044795A1 (enExample) |
| EP (1) | EP2883569B1 (enExample) |
| JP (1) | JP6339568B2 (enExample) |
| KR (1) | KR102149162B1 (enExample) |
| CN (1) | CN104519961A (enExample) |
| AR (1) | AR092086A1 (enExample) |
| BR (1) | BR112015002760A2 (enExample) |
| CA (1) | CA2881075A1 (enExample) |
| CL (1) | CL2014003510A1 (enExample) |
| CO (1) | CO7170177A2 (enExample) |
| ES (2) | ES2442242B1 (enExample) |
| IN (1) | IN2014MN02675A (enExample) |
| MX (1) | MX357828B (enExample) |
| PE (1) | PE20150616A1 (enExample) |
| RU (1) | RU2696497C2 (enExample) |
| TW (1) | TWI649084B (enExample) |
| WO (1) | WO2014023860A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2016003282A1 (es) | 2016-12-21 | 2017-08-18 | Univ Chile | Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1137401B1 (en) * | 1998-12-09 | 2005-11-23 | Chiron Corporation | Administration of neurotrophic agents to the central nervous system |
| AR022333A1 (es) | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
| US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
| US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
| ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
| US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
| AU2006282799B2 (en) * | 2005-08-26 | 2012-11-29 | Healthpartners Research & Education | Methods for treatment of headaches by administration of oxytocin |
| US9808509B2 (en) * | 2007-06-08 | 2017-11-07 | Healthpartners Research Foundation | Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
| AU2008297889A1 (en) * | 2007-09-14 | 2009-03-19 | Formycon Ag | Use of SLIT, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| PL2430977T3 (pl) | 2009-05-14 | 2020-08-24 | Biotechnology Institute, I Mas D, S.L. | Sposób preparowania co najmniej jednego związku z krwi i urządzenie do pobierania próbek do stosowania podczas realizacji wspomnianego sposobu |
| KR101114712B1 (ko) * | 2009-10-23 | 2012-02-29 | 세원셀론텍(주) | 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법 |
| ES2369945B1 (es) | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2012
- 2012-08-09 ES ES201200810A patent/ES2442242B1/es not_active Expired - Fee Related
-
2013
- 2013-07-19 JP JP2015525915A patent/JP6339568B2/ja not_active Expired - Fee Related
- 2013-07-19 ES ES13756518.0T patent/ES2662385T3/es active Active
- 2013-07-19 MX MX2015001677A patent/MX357828B/es active IP Right Grant
- 2013-07-19 TW TW102125858A patent/TWI649084B/zh not_active IP Right Cessation
- 2013-07-19 KR KR1020157001551A patent/KR102149162B1/ko not_active Expired - Fee Related
- 2013-07-19 RU RU2015104076A patent/RU2696497C2/ru active
- 2013-07-19 CN CN201380041280.4A patent/CN104519961A/zh active Pending
- 2013-07-19 WO PCT/ES2013/000176 patent/WO2014023860A1/es not_active Ceased
- 2013-07-19 CA CA2881075A patent/CA2881075A1/en not_active Abandoned
- 2013-07-19 BR BR112015002760A patent/BR112015002760A2/pt not_active Application Discontinuation
- 2013-07-19 PE PE2015000116A patent/PE20150616A1/es not_active Application Discontinuation
- 2013-07-19 EP EP13756518.0A patent/EP2883569B1/en not_active Not-in-force
- 2013-08-08 AR ARP130102835A patent/AR092086A1/es unknown
- 2013-08-08 US US13/962,340 patent/US20140044795A1/en not_active Abandoned
-
2014
- 2014-12-23 CL CL2014003510A patent/CL2014003510A1/es unknown
- 2014-12-31 IN IN2675MUN2014 patent/IN2014MN02675A/en unknown
-
2015
- 2015-01-20 CO CO15010369A patent/CO7170177A2/es unknown
-
2016
- 2016-03-08 US US15/063,969 patent/US20160184360A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2442242A1 (es) | 2014-02-10 |
| MX357828B (es) | 2018-07-25 |
| AR092086A1 (es) | 2015-03-25 |
| KR20150040860A (ko) | 2015-04-15 |
| MX2015001677A (es) | 2015-04-10 |
| CL2014003510A1 (es) | 2015-05-04 |
| KR102149162B1 (ko) | 2020-08-31 |
| EP2883569A1 (en) | 2015-06-17 |
| ES2662385T3 (es) | 2018-04-06 |
| TW201408310A (zh) | 2014-03-01 |
| EP2883569B1 (en) | 2017-12-20 |
| US20160184360A1 (en) | 2016-06-30 |
| RU2015104076A (ru) | 2016-09-27 |
| CA2881075A1 (en) | 2014-02-13 |
| CN104519961A (zh) | 2015-04-15 |
| TWI649084B (zh) | 2019-02-01 |
| US20140044795A1 (en) | 2014-02-13 |
| IN2014MN02675A (enExample) | 2015-08-28 |
| RU2696497C2 (ru) | 2019-08-02 |
| JP6339568B2 (ja) | 2018-06-06 |
| WO2014023860A1 (es) | 2014-02-13 |
| ES2442242B1 (es) | 2014-11-25 |
| CO7170177A2 (es) | 2015-01-28 |
| BR112015002760A2 (pt) | 2020-04-22 |
| JP2015524464A (ja) | 2015-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012644A (es) | Tratamiento de cataplejia. | |
| UA110813C2 (uk) | Лікування ліподистрофії | |
| CL2014003475A1 (es) | Forma c cristalina de acido obeticolico; proceso de preparacion de la forma 1 de acido obeticolico a partir de la forma c cristalina; composicion farmaceutica que comprende a una forma cristalina de acido obeticolico, util para el tratamiento o prevencion de una enfermedad hepatica colestasica, hepatopatia alcoholica y enfermedades cardiovasculares tal como aterosclerosis, entre otras. | |
| IT1405680B1 (it) | Processo per la produzione di l-fucosio. | |
| CL2014001339A1 (es) | Procedimiento de preparacion de un compuesto intermediario derivado de 5-fluoro-1h-pirazolopiridina; compuestos intermediarios que participan del mismo y formas cristalinas del compuesto final obtenido, el cual es util en el tratamiento de trastornos cardiocirculatorios. | |
| UA115231C2 (uk) | Сполуки імідазопіролідинонів | |
| GT201400191A (es) | Esketamina para el tratamiento de la depresión refractaria al tratamiento o resistente al tratamiento | |
| EA201201374A1 (ru) | Лечение атаксии-телеангиэктазии | |
| UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
| PE20151519A1 (es) | Composicion de liposoma | |
| GT201400111A (es) | Triazolopiridinas sustituidas | |
| BR112014007203A2 (pt) | composto, composição farmacêutica, método de tratamento, utilização de um composto, conjunto e invenção | |
| MX2012006233A (es) | Nuevos compuestos de espiropiperidina. | |
| EA201491286A1 (ru) | Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину | |
| GT201400022A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinolina util para el tratamiento de diabetes | |
| EA201200098A1 (ru) | Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия | |
| PE20140255A1 (es) | Tableta dispersable en forma oral | |
| BR112015007196A2 (pt) | processos em fase de solução para a fabricação de depsipeptídeos e novos intermediários | |
| MX353743B (es) | Metodo de tratamiento fungicida y/o bactericida de cepas resistentes por medio de uno o mas aceites esenciales. | |
| CR20110552A (es) | Tratamiento de transtornos resistentes a la insulina | |
| EA201600429A1 (ru) | Способ очистки 2,5-дихлорфенола | |
| LT2939665T (lt) | Farmacinė kompozicija, skirta živ infekcijų gydymui | |
| BR112014010278A2 (pt) | método de erradicar espécies indesejáveis de uma zona de tratamento, composição fumigante, e método de fazer uma composição fumigante | |
| CL2013000688A1 (es) | Procedimiento para obtener una composicion de igg a partir de una composicion de igg parcialmente purificada. | |
| CL2018001719A1 (es) | Tratamiento contra el mieloma múltiple (divisional solicitud 201600396) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |